...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Clinical Significance of Human Telomerase RNA Gene (hTERC) Amplification in Cervical Squamous Cell Lesions Detected by Fluorescence in Situ Hybridization
【24h】

Clinical Significance of Human Telomerase RNA Gene (hTERC) Amplification in Cervical Squamous Cell Lesions Detected by Fluorescence in Situ Hybridization

机译:人端粒酶RNA基因(hTERC)扩增在宫颈鳞状细胞病变中的荧光原位杂交检测的临床意义。

获取原文
           

摘要

Background: Genomic amplification of the human telomerase RNA gene (hTERC), located in thechromosome 3q26 region, has been documented in tumorigenesis. The present study was designed to detecthTERC amplification in cervical lesions and evaluate whether this might serve as a supportive biomarkerto cytopathology or histopathology in the diagnosis of cervical lesions. Methods: Liquid-based thin-layercytopathologic examination and detection of amplification by fluorescence in situ hybridization (FISH) wasconducted in 130 women, along with assessment of human papillomavirus DNA, colposcopy with biopsy, andhistopathologic examination. Results: In cytopathologic examinations, hTERC amplification rates for negativefor intraepithelial lesion or malignancy (NILM),atypical squamous cells of undetermined significance (ASCUS),low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL) andsquamous cell carcinoma (SCC) cases were 0% (0/10), 4% (1/25), 20% (6/30), 77% (27/35), and 100% (10/10),respectively. The difference among abnormal cellular change groups was statistically significant (P<0.05). Inhistopathologic examinations, hTERC amplification rates in normal squamous cell with or without inflammatory,cervical intraepithelial neoplasia 1 (CIN 1), CIN 2, CIN 3 and SCC cases were 3.8% (2/52), 18.2% (6/33), 66.7%(6/9), 84.6% (22/26), 100% (10/10), respectively. There were significant differences among CIN1, CIN2, CIN3and SCC cases (P<0.05). The hTERC amplification was more specific than HPV positivity in differentiating lowgradefrom high-grade cervical disorders (specificity: 88.5% vs. 70.8%, P<0.05). Conclusions: FISH detectionof hTERC amplification could be an effective adjunct to cytopathologic or histopathologic examination fordifferential diagnosis of low- and high-grade cervical squamous cell disorders.
机译:背景:位于染色体3q26区的人类端粒酶RNA基因(hTERC)的基因组扩增已在肿瘤发生中进行了记录。本研究旨在检测宫颈病变中的hTERC扩增,并评估其在宫颈病变的诊断中是否可作为支持性生物标志物的细胞病理学或组织病理学。方法:对130名妇女进行了液基薄层细胞病理学检查和荧光原位杂交(FISH)扩增检测,并评估了人乳头瘤病毒DNA,阴道镜活检和组织病理学检查。结果:在细胞病理学检查中,上皮内病变或恶性肿瘤(NILM),非典型意义的非典型鳞状细胞(ASCUS),低度鳞状上皮内病变(LSIL),高级别鳞状上皮内和病变(HSC)阴性的hTERC扩增率癌(SCC)分别为0%(0/10),4%(1/25),20%(6/30),77%(27/35)和100%(10/10)。异常细胞变化组之间的差异具有统计学意义(P <0.05)。组织病理学检查,有或无炎症,宫颈上皮内瘤变1​​(CIN 1),CIN 2,CIN 3和SCC的正常鳞状细胞hTERC扩增率为3.8%(2/52),18.2%(6/33),66.7 %(6/9),84.6%(22/26),100%(10/10)。 CIN1,CIN2,CIN3和SCC病例之间差异有统计学意义(P <0.05)。 hTERC扩增在区分低度和高度宫颈疾病方面比HPV阳性更具特异性(特异性:88.5%vs. 70.8%,P <0.05)。结论:FISH检测hTERC扩增可作为细胞病理学或组织病理学检查的有效辅助手段,以鉴别诊断低度和高度宫颈鳞状细胞疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号